Overview

Effect of Olopatadine on Allergic Tear Mediators

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the research is to determine which inflammatory substances are involved in causing allergic symptoms in the eye. Allergic conjunctivitis is a common problem with symptoms of temporary redness, itching, tearing, and swelling of the eyes. Substances released by cells in the affected tissues cause allergic reactions in the eye and elsewhere in the body.
Phase:
N/A
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborator:
National Eye Institute (NEI)
Treatments:
Olopatadine Hydrochloride